Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bioadaptives (BDPT) Preferred Shares (2021 - 2025)

Bioadaptives' Preferred Shares history spans 5 years, with the latest figure at $100.0 for Q4 2025.

  • On a quarterly basis, Preferred Shares changed 0.0% to $100.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $100.0, a 0.0% change, with the full-year FY2025 number at $100.0, changed 0.0% from a year prior.
  • Preferred Shares hit $100.0 in Q4 2025 for Bioadaptives, roughly flat from $100.0 in the prior quarter.
  • Over the last five years, Preferred Shares for BDPT hit a ceiling of $335.0 in Q1 2024 and a floor of $1.0 in Q4 2023.
  • Historically, Preferred Shares has averaged $159.81 across 5 years, with a median of $160.0 in 2021.
  • Biggest five-year swings in Preferred Shares: surged 9900.0% in 2024 and later crashed 99.66% in 2025.
  • Tracing BDPT's Preferred Shares over 5 years: stood at $160.0 in 2021, then changed by 0.0% to $160.0 in 2022, then plummeted by 99.38% to $1.0 in 2023, then surged by 9900.0% to $100.0 in 2024, then changed by 0.0% to $100.0 in 2025.
  • Business Quant data shows Preferred Shares for BDPT at $100.0 in Q4 2025, $100.0 in Q3 2025, and $1.0 in Q2 2025.